Showing results (81-90 of 344) with videos related to

Sort By:
Pageof 35
Cancer Research and Treatment|October 13, 2022
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain MetastasisHongsik Kim, Sehhoon Park, Hyun Ae Jung, et al.
Oncology|November 13, 2010
Prognostic model to predict outcomes in non-small cell lung cancer patients with erlotinib as salvage treatmentSeung Tae Kim, Jeeyun Lee, Jong-Mu Sun, et al.
Scientific Reports|October 3, 2019
Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumabYeonghee Eun, In Young Kim, Jong-Mu Sun, et al.
Molecular and Cellular Neurosciences|May 4, 2004
Reduced GABAergic transmission and number of hippocampal perisomatic inhibitory synapses in juvenile mice deficient in the neural cell adhesion molecule L1Armen K Saghatelyan, Alexander G Nikonenko, Mu Sun, et al.
BMC Infectious Diseases|May 11, 2017
A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, ChinaLuodan Suo, Li Lu, Juan Li, et al.
Plos One|April 12, 2018
Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical modelBo Mi Ku, Moon Ki Choi, Jong-Mu Sun, et al.
Investigational New Drugs|October 25, 2014
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancerBo Mi Ku, Eun Hye Jho, Yeon-Hee Bae, et al.
Cancer Research and Treatment|July 26, 2024
Salvage Radiotherapy for Loco-regional Recurrence of Esophageal Cancer Following SurgeryWon Kyung Cho, Jae Myoung Noh, Dongryul Oh, et al.
BMC Cancer|August 8, 2020
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in KoreaHyera Kim, Minsuk Kwon, Binnari Kim, et al.
Translational Lung Cancer Research|November 19, 2020
The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancerHyun Ae Jung, Sook Young Woo, Se-Hoon Lee, et al.
Pageof 35